Search results
Author(s):
William Foster
,
Mark Sopher
Added:
3 years ago
In 1966, following the death of his mentor Professor Harry Heller from ventricular tachycardia (VT), Michel Mirowski began to research a way to prevent future deaths from ventricular arrhythmia, working with Morton Mower and William Staewen in Sinai Hospital, Baltimore. The first human implant of an automated implanted cardioverter defibrillator (ICD) took place in 1980 amid much criticism and…
View more
Author(s):
Bosede A Afolabi
,
Fred M Kusumoto
Added:
3 years ago
Since the first implantable pacemaker was introduced in 1958, electronic devices designed to treat cardiac problems have experienced technological leaps. A rapidly expanding number of patients depend on this technology.1 Cardiovascular implantable electronic devices (CIEDs) now include implantable cardioverter defibrillators (ICDs), pacemakers (PMs), cardiac resynchronisation therapy (CRT)…
View more
Author(s):
Ali Vazir
,
Martin R Cowie
Added:
3 years ago
Acute heart failure is usually defined as the rapid onset of, or change in, signs and/or symptoms of heart failure resulting in the need for urgent treatment.1 It can occur as the first manifestation of a failing heart (acute de novo heart failure) or it can occur in a patient with a chronic history of heart failure, in which case the term ‘acute decompensation’ is often applied.
The acute heart…
View more
Author(s):
Bao Tran
,
Gregg C Fonarow
Added:
3 years ago
Heart failure (HF) remains a major public health problem resulting in substantial morbidity, mortality and healthcare expenditures globally. The European Society of Cardiology (ESC) 2012 Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure and the American College of Cardiology Foundation (ACCF)/American Heart Association (AHA) 2013 Guideline for the Management of Heart…
View more
Author(s):
Jose Luis Zamorano
Added:
3 years ago
Heart failure (HF) is a growing and increasingly important chronic disease of the Western world, occurring in at least 2% of the adult population and rising to 3% in those aged over 75 years. It is characterised by inadequate systemic perfusion due to impairment of the cardiac pump function. Clinical HF is a progressive condition, typically with high morbidity and mortality rates. It therefore…
View more
Author(s):
Jose Luis Zamorano
Added:
3 years ago
Heart failure (HF) is a growing and increasingly important chronic disease of the Western world, occurring in at least 2% of the adult population and rising to 3% in those aged over 75 years.1 It is characterised by inadequate systemic perfusion due to impairment of the cardiac pump function. Clinical HF is a progressive condition, typically with high morbidity and mortality rates. It therefore…
View more
Author(s):
Matthew McKillop
Added:
1 year ago
HRX 22 - Dr Matthew McKillop from ReadmyRhythm joins us to outline a new wearable heart monitoring platform to identify and diagnose cardiac arrhythmias in users.
Questions:
1. What are the clinical unmet needs that led to the creation of this technology?
2. What is ReadmyRhythm?
3. What is the data underpinning the use of this technology, and what future study is planned?
4. How can this…
View more
Author(s):
Ewa Piotrowicz
,
Ryszard Piotrowicz
Added:
3 years ago
Telemedicine (TM) (see Table 1) finds its application most commonly in chronic heart failure (HF).1–3 TM can be useful during exercise training (ET) as a tool to control stability of the clinical status of patients and to supervise training sessions. These goals can be achieved by monitoring clinical symptoms (dyspnoea, fatigue, oedema, chest pain, palpitations, etc.) and monitoring parameters …
View more
Author(s):
Martin R Cowie
Added:
3 years ago
Management of heart failure consumes 1% to 2% of the healthcare budget in developed countries, with the largest share due to the cost of hospitalisations.1 A pan-European survey has shown that up to 65% of patients hospitalised with heart failure have a past history of chronic heart failure.2 Such admissions are usually long, with an average duration of 11 days. In-hospital mortality was reported…
View more
Author(s):
Veli-Pekka Harjola
Added:
3 years ago
Heart failure (HF) is a clinical syndrome characterised by inadequate systemic perfusion to meet the body's metabolic demands as a result of impaired cardiac pump function. It is one of the leading cardiovascular health problems in Europe, and its incidence, particularly in the elderly, continues to increase despite an intensive effort to increase education and delivery of healthcare to affected…
View more